ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025
AD Workbench: Transforming Alzheimer's research with secure, global, and collaborative data sharing and analysis.
Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Agentic AI for scaling diagnosis and care in neurodegenerative disease.Nature aging · 2026Review
- Digital speech-based markers to advance prognosis in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Article
- Gender differences in informal caregiving costs and burden in Alzheimer disease: a multinational cross-sectional analysis.BMC public health · 2026Article
- Advancing global dementia research through equity and inclusion.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Article
- Agentic AI for automated hypothesis testing in Alzheimer's disease and related dementias.medRxiv : the preprint server for health sciences · 2025Article
- AI models, bias and data sharing efforts to tackle Alzheimer's disease and related dementias.The journal of prevention of Alzheimer's disease · 2025Article
- Towards an AI biomedical scientist: Accelerating discoveries in neurodegenerative disease.The journal of prevention of Alzheimer's disease · 2025Article
- Solving the 'Goldilocks problem' in dementia clinical trials with multimodal AI.The journal of prevention of Alzheimer's disease · 2025Article
- Formal and Informal Care Utilization in Mild Cognitive Impairment and Mild Dementia due to Alzheimer's Disease: Cross-Sectional and Longitudinal Analyses of RUD-Lite Data from the Tauriel Study.Dementia and geriatric cognitive disorders · 2025Article
- The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging.Nature medicine · 2025Article
- AD Workbench: Transforming Alzheimer's research with secure, global, and collaborative data sharing and analysis.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe Alzheimer's Disease Data Initiative (AD Data Initiative) is a global coalition of partners accelerating scientific discoveries in Alzheimer's disease (AD) and related dementias (ADRD) by breaking down data silos, eliminating barriers to research, and fostering collaboration among scientists studying these issues.
methodsThe flagship product of the AD Data Initiative technical suite is AD Workbench, a secure, cloud-based environment that enables global access, analysis, and sharing of datasets, as well as interoperability with other key data platforms.
resultsAs of April 7, 2025, AD Workbench has 6178 registered users from 115 countries, including 886 users from 60 low- and middle-income countries. On average, more than 500 users, including over 100 new users, log in each month to discover data and conduct integrative analyses. DISCUSSION: By prioritizing interoperability and robust security within a collaborative framework, AD Workbench is well positioned to drive advancements in AD treatments and diagnostic tools. HIGHLIGHTS: Data sharing Interoperability Cloud-based analytics Collaborative workspace.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.